Skip to main content

Startups & scaleups

Startups and scaleups lead growth in the BioRegion. In 2022, they secured a joint total of €445 million in investment. Since 2013, the startup creation rate has been over 50 companies/year. Of the life sciences and healthcare startups in Catalonia, 26% are spinoffs from a research organization and 32% of the emerging companies are led by women.

 splicebio

Splice Bio

Splice Bio uses protein splicing to push the limits of adeno-associated virus (AAV) vector applications and develop gene therapies for large genes.

Sector: Biotec
Subsector: Medicines and diagnosis
Creation of startups and spinoffs

The digital health subsector fuels growth of startups

The creation of digital health startups and spinoffs fuels the sector’s growthThe graph shows the startups created between 2013 and 2020 in the various subsectors. The percentage shows how many are spinoffs of research organizations
Digital health startups

These saw over €39 million in investment and turnover of €356 million in 2022

Of the 212 digital health startups in the BioRegion, 95% were established in the past 10 years. This increase reflects the youth and explosive growth of this subsector, with joint turnover of €356 million. In 2021, investment in digital health companies peaked (€63 million), stabilizing at €39 million in 2022. However, the digital health market is expected to continue growing globally at 16.5% per year, as the Digital Health in Catalonia report by ACCIÓ and Biocat reflects.

Check out the Digital Health in Catalonia report
Investment secured

Surpassing all expectations

The investment secured by startups in the BioRegion grew x4 between 2018 and 2022, when we saw the first megaround in medtech company Impress (€122 million) and 2 rounds +€50 million in the biotech segment (Minoryx and SpliceBio).

Imatge
Inversió captada per startups de la BioRegió 2018-2022

Featured startups

 impress

Impress

Impress specializes in invisible orthodontics and uses the most advanced technology for diagnosing and improving oral health. They closed a €122 million round in 2022.

Sector: Tecmed
Subsector: Medical devices
Minoryx Therapeutics

Minoryx Therapeutics

Minoryx develops therapies for orphan diseases of the central nervous system. In May 2022, the company closed a €51 million Series C round and in November licensed its drug leriglitazone for X-ALD.

Sector: Biotec
Subsector: Medicines and diagnosis
 splicebio

Splice Bio

Splice Bio uses protein splicing to push the limits of adeno-associated virus (AAV) vector applications and develop gene therapies for large genes.

Sector: Biotec
Subsector: Medicines and diagnosis
Starlab

Starlab

Starlab provides latest generation data analysis services in neuroscience. They have telemedicine platforms to diagnose and treat the human brain.

Sector: Tecmed
Subsector: Medical devices
HumanITCare

HumanITCare

HumanITCare has developed a telemedicine platform that allows for remote medical monitoring, provides at home care and compiles data in real time for research.

Sector: Digital health
Subsector: Digital therapies (DTx)
Mowoot

UsMIMA (MowoOt)

UsMIMA has developed a medical device (MowoOt), inspired by the abdominal massages of the Institut Guttman therapists, for chronic constipation. It is the first startup created from the d·HEALTH Barcelona program.

Sector: Tecmed
Subsector: Medical devices
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.